Peptide-Based HDL as an Effective Delivery System for Lipophilic Drugs to Restrain Atherosclerosis Development

PURPOSE: Peptide-based high-density lipoprotein (pHDL) structurally and functionally resembles the natural HDL as anti-atherosclerosis (AS) therapies. Since pHDL contains a large hydrophobic core, this study aims to evaluate the potentials of pHDL as a hydrophobic drug carrier and the efficiency of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Junwei, Li, Ziyun, Li, Jing, Song, Ping, Yang, Jinsheng, Xiao, Wei, Li, Ning, Xu, Ruodan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464027/
https://www.ncbi.nlm.nih.gov/pubmed/36097444
http://dx.doi.org/10.2147/IJN.S374736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464027/
https://www.ncbi.nlm.nih.gov/pubmed/36097444
http://dx.doi.org/10.2147/IJN.S374736

Ejemplares similares